Gaviscon oralna suspenzija
Name | Gaviscon oralna suspenzija |
---|---|
Marketing Authorisation Number | HR-H-824012801 |
Active Substance | natrijev alginat natrijev hidrogenkarbonat kalcijev karbonat |
Composition | 10 ml oralne suspenzije sadrži 500 mg natrijevog alginata, 267 mg natrijevog hidrogenkarbonata i 160 mg kalcijevog karbonata |
Pharmaceutical Form | oralna suspenzija |
Manufacturer | RB NL Brands B.V., Schiphol, Nizozemska |
Marketing Authorisation Holder | Reckitt Benckiser d.o.o., Ulica grada Vukovara 269d, Zagreb, Hrvatska |
Marketing Authorisation Date | 10.02.2022 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/17-02/488 |
Registration Number | 381-12-01/154-22-10 |
Prescription | bez recepta |
Distribution | u ljekarni |
Advertising to general public | dopušteno |
ATC Code | A02BX13 |
Medicinal product marketed in the Croatia | Privremeni prekid opskrbe |
SmPC | download |
PL | download |